Julie Garlikov Net Worth

The estimated Net Worth of Julie Garlikov is at least $80 dollars as of 11 May 2023. Ms. Garlikov owns over 858 units of NewAge Inc stock worth over $80 and over the last 5 years she sold NBEV stock worth over $0. In addition, she makes $0 as Chief Marketing Officer at NewAge Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Garlikov NBEV stock SEC Form 4 insiders trading

Julie has made over 1 trades of the NewAge Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 858 units of NBEV stock worth $80 on 11 May 2023.

The largest trade she's ever made was exercising 858 units of NewAge Inc stock on 11 May 2023 worth over $80. On average, Julie trades about 143 units every 0 days since 2019. As of 11 May 2023 she still owns at least 858 units of NewAge Inc stock.

You can see the complete history of Ms. Garlikov stock trades at the bottom of the page.

Julie Garlikov biography

Julie Garlikov serves as Chief Marketing Officer of the Company. Ms. Garlikov brings over two decades of senior-level marketing experience with world-class packaged-goods companies. From January through November 2019, Ms. Garlikov served as Chief Marketing Officer for Shaklee, a leading natural nutrition company. From December 2015 through January 2019, Ms. Garlikov served as Vice President and as Head of Global Brand Marketing for Rodan + Fields, a leading global skincare company. Prior to Rodan + Fields, from June 2014 to December 2015 Ms. Garlikov was Vice President of Marketing at Nuvesse Skin Therapies, a startup company commercializing aesthetic skin-care products. Ms. Garlikov began her career at the Procter and Gamble Company and held commercial leadership roles of increasing responsibility at Johnson & Johnson, Allergan, PepsiCo, and Torani.

How old is Julie Garlikov?

Julie Garlikov is 49, she's been the Chief Marketing Officer of NewAge Inc since 2019. There are 11 older and 2 younger executives at NewAge Inc. The oldest executive at NewAge Inc is Timothy Haas, 73, who is the Independent Director.

What's Julie Garlikov's mailing address?

Julie's mailing address filed with the SEC is C/O NOVABAY PHARMACEUTICALS, INC., 2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA, 94608.

Insiders trading at NewAge Inc

Over the last 8 years, insiders at NewAge Inc have traded over $5,766,131 worth of NewAge Inc stock and bought 2,481,821 units worth $3,914,047 . The most active insiders traders include Ed Brennan, Brent D Willis a Timothy J Haas. On average, NewAge Inc executives and independent directors trade stock every 70 days with the average trade being worth of $13,942. The most recent stock trade was executed by Ed Brennan on 18 November 2021, trading 500,000 units of NBEV stock currently worth $610,000.

What does NewAge Inc do?

Complete history of Ms. Garlikov stock trades at NewAge Inc a Novabay Pharmaceuticals Inc

NewAge Inc executives and stock owners

NewAge Inc executives and other stock owners filed with the SEC include:

• Gregory Gould,
  Chief Financial Officer
• Brent Willis,
  Chief Executive Officer, Director
• Brent David Willis,
  CEO & Director
• Gregory Fea,
  Independent Chairman of the Board
• Randall Smith,
  President - Morinda Holdings, Inc
• Amy Kuzdowicz,
  Independent Director
• Timothy Haas,
  Independent Director
• Ed Brennan,
  Independent Director
• Frederick Cooper,
  Director
• John Mills,
  Investor Relation Officer
• Alicia Syrett,
  Independent Director
• Julie Garlikov,
  Chief Marketing Officer
• Kelly Olsen,
  Chief Commercial Officer
• Jay Barrow,
  Head of Brand
• Carin Casso Reinhardt,
  Chief People Officer
• Karima McDaniel,
  Chief Marketing Officer
• Michael Cunningham,
  Sr. VP of Sales
• Jennifer S. Grafton,
  Sr. VP & Gen. Counsel
• Lisa Mueller,
  VP of Investor Relations
• Kevin Manion,
  Chief Financial Officer.
• Mark H. Wilson,
  Group Pres
• Julie Anderson,
  
• Neil Fallon,
  
• Reginald Kapteyn,
  Director
• David Vanderveen,
  Chief Operating Officer
• Robert J. Evans,
  
• Kevin Manion,
  Chief Financial Officer
• Fred W Cooper,
  Director